Literature DB >> 8842486

Similarities and differences between the vascular endothelial growth factor (VEGF) splice variants.

G Neufeld1, T Cohen, H Gitay-Goren, Z Poltorak, S Tessler, R Sharon, S Gengrinovitch, B Z Levi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8842486     DOI： 10.1007/bf00437467

Source DB:  PubMed          Journal:  Cancer Metastasis Rev        ISSN： 0167-7659            Impact factor:   9.264


× No keyword cloud information.
  48 in total

1.  Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells.

Authors:  N Ferrara; W J Henzel
Journal:  Biochem Biophys Res Commun       Date:  1989-06-15       Impact factor: 3.575

2.  The binding of vascular endothelial growth factor to its receptors is dependent on cell surface-associated heparin-like molecules.

Authors:  H Gitay-Goren; S Soker; I Vlodavsky; G Neufeld
Journal:  J Biol Chem       Date:  1992-03-25       Impact factor: 5.157

Review 3.  Involvement of heparan sulfate and related molecules in sequestration and growth promoting activity of fibroblast growth factor.

Authors:  I Vlodavsky; H Q Miao; B Medalion; P Danagher; D Ron
Journal:  Cancer Metastasis Rev       Date:  1996-06       Impact factor: 9.264

4.  Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor.

Authors:  D Maglione; V Guerriero; G Viglietto; P Delli-Bovi; M G Persico
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-15       Impact factor: 11.205

5.  Heparin modulates the interaction of VEGF165 with soluble and cell associated flk-1 receptors.

Authors:  S Tessler; P Rockwell; D Hicklin; T Cohen; B Z Levi; L Witte; I R Lemischka; G Neufeld
Journal:  J Biol Chem       Date:  1994-04-29       Impact factor: 5.157

6.  Epidermal growth factor suppresses nitric oxide and hydrogen peroxide production by keratinocytes. Potential role for nitric oxide in the regulation of wound healing.

Authors:  D E Heck; D L Laskin; C R Gardner; J D Laskin
Journal:  J Biol Chem       Date:  1992-10-25       Impact factor: 5.157

7.  Characterization of novel vascular endothelial growth factor (VEGF) receptors on tumor cells that bind VEGF165 via its exon 7-encoded domain.

Authors:  S Soker; H Fidder; G Neufeld; M Klagsbrun
Journal:  J Biol Chem       Date:  1996-03-08       Impact factor: 5.157

8.  Selective binding of VEGF121 to one of the three vascular endothelial growth factor receptors of vascular endothelial cells.

Authors:  H Gitay-Goren; T Cohen; S Tessler; S Soker; S Gengrinovitch; P Rockwell; M Klagsbrun; B Z Levi; G Neufeld
Journal:  J Biol Chem       Date:  1996-03-08       Impact factor: 5.157

Review 9.  Angiogenesis in cancer, vascular, rheumatoid and other disease.

Authors:  J Folkman
Journal:  Nat Med       Date:  1995-01       Impact factor: 53.440

10.  Expression of vascular endothelial growth factor and its receptors in human renal ontogenesis and in adult kidney.

Authors:  M Simon; H J Gröne; O Jöhren; J Kullmer; K H Plate; W Risau; E Fuchs
Journal:  Am J Physiol       Date:  1995-02
View more
  19 in total

1.  Vascular endothelial growth factor stimulates dephosphorylation of the catenins p120 and p100 in endothelial cells.

Authors:  E Y Wong; L Morgan; C Smales; P Lang; S E Gubby; J M Staddon
Journal:  Biochem J       Date:  2000-02-15       Impact factor: 3.857

2.  Substitution of C-terminus of VEGFR-2 with VEGFR-1 promotes VEGFR-1 activation and endothelial cell proliferation.

Authors:  Rosana D Meyer; Amrik Singh; Fredric Majnoun; Catharina Latz; Kameran Lashkari; Nader Rahimi
Journal:  Oncogene       Date:  2004-07-15       Impact factor: 9.867

3.  Intracerebral tumor-associated hemorrhage caused by overexpression of the vascular endothelial growth factor isoforms VEGF121 and VEGF165 but not VEGF189.

Authors:  S Y Cheng; M Nagane; H S Huang; W K Cavenee
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-28       Impact factor: 11.205

Review 4.  Molecular predictors of clinical outcome in patients with head and neck squamous cell carcinoma.

Authors:  Giovana R Thomas; Hari Nadiminti; Jacinto Regalado
Journal:  Int J Exp Pathol       Date:  2005-12       Impact factor: 1.925

5.  Anchorage of VEGF to the extracellular matrix conveys differential signaling responses to endothelial cells.

Authors:  Tom T Chen; Alfonso Luque; Sunyoung Lee; Sean M Anderson; Tatiana Segura; M Luisa Iruela-Arispe
Journal:  J Cell Biol       Date:  2010-02-22       Impact factor: 10.539

6.  VEGF-A and VEGF-B mRNA expression in gastro-oesophageal cancers.

Authors:  Cristina Angelescu; Florin Burada; Mihai Ioana; Radu Angelescu; Emil Moraru; Anca Riza; Sanda Marchian; Francisc Mixich; Mihai Cruce; Adrian Săftoiu
Journal:  Clin Transl Oncol       Date:  2012-08-08       Impact factor: 3.405

7.  Expression of pro-angiogenic growth factors VEGF, EGF and bFGF and their topographical relation to neovascularisation in prostate cancer.

Authors:  Lutz Trojan; Daniel Thomas; Thomas Knoll; Rainer Grobholz; Peter Alken; Maurice Stephan Michel
Journal:  Urol Res       Date:  2004-05

8.  HSPG-binding peptide corresponding to the exon 6a-encoded domain of VEGF inhibits tumor growth by blocking angiogenesis in murine model.

Authors:  Tong-Young Lee; Judah Folkman; Kashi Javaherian
Journal:  PLoS One       Date:  2010-04-01       Impact factor: 3.240

9.  Anti-human vascular endothelial growth factor (VEGF) antibody selection for immunohistochemical staining of proliferating blood vessels.

Authors:  Chris M van der Loos; Lorine B Meijer-Jorna; Marloes E C Broekmans; Hanneke P H M Ploegmakers; Peter Teeling; Onno J de Boer; Allard C van der Wal
Journal:  J Histochem Cytochem       Date:  2010-02       Impact factor: 2.479

10.  2-Methoxyestradiol exhibits a biphasic effect on VEGF-A in tumor cells and upregulation is mediated through ER-alpha: a possible signaling pathway associated with the impact of 2-ME2 on proliferative cells.

Authors:  Samarendra N Banerjee; Krishanu Sengupta; Snigdha Banerjee; Neela K Saxena; Sushanta K Banerjee
Journal:  Neoplasia       Date:  2003 Sep-Oct       Impact factor: 5.715
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.